This year our most read and highly rated articles focused on H1N1 and practice issues, and they are still important reading. Medscape Internal Medicine
Source:The Year's Top 10 Featured Articles on Medscape
The U.S. Food and Drug Administration said on Tuesday that AstraZeneca’s MedImmune unit is voluntarily recalling some of its H1N1 swine flu vaccine because it was not as potent as it should be. Reuters Health Information
Source:Another Drugmaker Recalls Swine Flu Vaccine in U.S.
Although widely used in adults, serotonin receptor agonists for adolescents with migraine are still being studied. This review summarizes what we know to date. Pediatric Pharmacotherapy
Source:Use of Serotonin Receptor Agonists in Adolescents with Migraines: Focus on Almotriptan
Using a subjective measure like the OSA-18 may be less costly and more readily available, but it has poor sensitivity and low negative predictive value in detecting moderate to severe OSA. Medscape Medical News
Source:OSA-18 Quality-of-Life Questionnaire Does Not Detect Obstructive Sleep Apnea in Children
In a randomized trial, one 15-microgram dose of vaccine against 2009 influenza A (H1N1) was safe and immunogenic in infants and children 6 months of age or older. Medscape Medical News
Source:One 15-microgram Dose of H1N1 Vaccine May Suffice in Infants and Children